Patexia. Community

Innovation, Technology, and IP News

Limiting Terms in Preamble May Render Entire Preamble Limiting

BIO-RAD LABORATORIES, INC. v. 10X GENOMICS INC. Before Newman, O’Malley, and Taranto.  Appeal from the United States District Court for the District of Delaware. Summary...

Claims Covering Human Engineering That Exploits a Naturally-Occurring Phenomenon Are Patent Eligible

ILLUMINA, INC. v. ARIOSA DIAGNOSTICS, INC. Before Lourie, Moore, and Reyna. Modified opinion following Ariosa rehearing petition. Summary: The Federal Circuit modified its earlier...

PTAB Trial Fees Increase 25% in October

AIA Trial Fees Increasing + New Pro Hac Fee The United States Patent and Trademark Office (USPTO) is increasing Patent and Patent Trial and Appeal Board (PTAB) fees for a second time...

The Definition of “Half-Liquid” Is Only Half Baked

IBSA INSTITUT BIOCHIMIQUE, S.A. V. TEVA PHARMACEUTICALS USA, INC. Before Prost, Reyna, and Hughes.  Appeal from the District Court of Delaware Summary: A term may be indefinite...

Fresh From the Bench: Latest Federal Circuit Court Case

CASE OF THE WEEK American Axle & Manufacturing, Inc. v. Neapco Holdings LLC, Appeal No. 2018-1763 (Fed. Cir. July 31, 2020) In this week’s Case of the Week, the Federal...

Novartis AG: Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial of hydroxychloroquine in... Read More »
Automobiles, smartphones, laptops, medical devices, among other end products, contain scores of individual components supplied by vendors. For end products sold... Read More »
In January, the USPTO announced it would seek comments on the new Guidance it had published on patent subject matter eligibility. We have previously discussed this... Read More »
Review it please. This can be a good article to read and if found possible try to share with your friends if you find useful for them
Tesla Inc reported a net profit, positive cash flow and wider-than-expected margins for the latest quarter on Wednesday, delivering on Chief Executive Elon Musk's... Read More »
If you look through the U.S. Patent Office’s online database, you’ll find some head-scratching proposals for inventions: for a plan to stack airplane... Read More »
For "X" drug, I prepared solvate "Xz." Using "Xz" I prepared Granules Dosage Form. Over the period of stability I found that solvate... Read More »
Total Approved NMEs: 46 Small Molecules: 34 (74 %) Biologics: 12 (26 %) This is second best production rate of approvals since 1996 when 53 NME's... Read More »
Patent Application is related to accurate capability for determining whether a Luciferian may be rehabilitated. As per Patent Specification (Paragraph: 0006)... Read More »
Comments
Pooja ShahCommendable!! There are many Luciferians in this world of mean and materialism :) Rehabilitation patent can be of major use and exploitation!!
Dec 30, 2017
Sanofi's Admelog (Short Acting Insulin) approved as a "follow-on product" on December 11, 2017 by US FDA's 505(b)(2) pathway. ... Read More »
The new standard, ITU Y.2241, details a web service framework to support ‘ubiquitous self-directed learning’ in future networks. It supports adaptive... Read More »
Comments
Sub poenaThis Recommendation ITU-T Y.2241 provides a framework to support a web objects based ubiquitous self-directed learning (uSDL) service including overview, content object model, functional capabilities, security and trust considerations of web objects based uSDL
Nov 6, 2017
Written by Scott Siera, Ph.D. and Eric Furman, Ph.D. Seven years after Mylotarg® (gemtuzumab ozogamicin) was voluntarily withdrawn from the market, the U.S... Read More »
Written by Damien Howard and Ronald J. Schoenbaum The Federal Circuit recently decided a patent subject-matter eligibility case relating to computer memory in... Read More »
If you live or work in the part of the country between Atlanta and Charlotte, I have some information that might be of interest to you.  Clemson University... Read More »
Written by Peter Heuser, Schwabe, Williamson & Wyatt, P.C. The big news this week (and it is particularly big news in Tyler and Marshall, Texas) is that the... Read More »
There was a flurry of activity in March, with a record number of Section 101 decisions.  The Federal Circuit issued 11 decisions alone (its highest monthly... Read More »
In a recent decision, the Federal Circuit continued to raise high eligibility hurdles for fintech software patents inventions. In Clarilogic, Inc. v. FormFree Holdings ... Read More »
Show more Newsfeed posts